Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma.

Coleman SJ, Grose RP, Kocher HM.

J Hepatocell Carcinoma. 2014 May 29;1:43-54. doi: 10.2147/JHC.S48958. eCollection 2014. Review.

2.

Molecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma.

Lili LN, Matyunina LV, Walker LD, Benigno BB, McDonald JF.

Biomed Res Int. 2013;2013:846387. doi: 10.1155/2013/846387. Epub 2013 May 9.

3.

Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.

Beer LA, Wang H, Tang HY, Cao Z, Chang-Wong T, Tanyi JL, Zhang R, Liu Q, Speicher DW.

PLoS One. 2013;8(3):e60129. doi: 10.1371/journal.pone.0060129. Epub 2013 Mar 27.

4.

The role of annexin A2 in tumorigenesis and cancer progression.

Lokman NA, Ween MP, Oehler MK, Ricciardelli C.

Cancer Microenviron. 2011 Aug;4(2):199-208. doi: 10.1007/s12307-011-0064-9. Epub 2011 Mar 5.

5.

Ion-permeable membrane for on-chip preconcentration and separation of cancer marker proteins.

Nge PN, Yang W, Pagaduan JV, Woolley AT.

Electrophoresis. 2011 May;32(10):1133-40. doi: 10.1002/elps.201000698.

6.

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.

Kothandaraman N, Bajic VB, Brendan PN, Huak CY, Keow PB, Razvi K, Salto-Tellez M, Choolani M.

BMC Cancer. 2010 Feb 24;10:64. doi: 10.1186/1471-2407-10-64.

Supplemental Content

Support Center